Cookies on the BTG website

We use cookies to ensure that we give you the best experience on our website.

If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the BTG website.

Find out more
Continue

Media

Utilities
Print
Email
Email to a friend
Email to a friend

* Required

BTG plc: Appointment of Non-executive Director

London, UK, 11 December 2012: BTG plc (LSE: BTG), the specialist healthcare company, today announces the appointment of Richard Wohanka as a non-executive director of the Board, effective from 1 January 2013.

Richard Wohanka has more than twenty years' experience in building asset management businesses. He was CEO of Union Bancaire Privée Asset Management between October 2009 and June 2012, and from 2001 to 2009 he was CEO of Fortis Investment Management. Mr Wohanka is a board member of the Nuclear Liabilities Fund and of the charity United Response.
Garry Watts, BTG's Chairman, commented: "Richard brings a wealth of business experience to BTG, including a deep understanding of the financial markets and company strategies that create value. We look forward to working with him as BTG continues to build its business."

There are no further details to be disclosed in relation to paragraph 9.6.13R of the Financial Services Authority Listing Rules.

For further information please contact:

BTG
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530605

Rolf Soderstrom, Chief Financial Officer
+44 (0)20 7575 0000

FTI Consulting
Ben Atwell/Simon Conway
+44 (0)20 7831 3113

About BTG
BTG is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programmes and products to develop and market to specialist physicians.